To include your compound in the COVID-19 Resource Center, submit it here.

Hydroxychloroquine: Completed Phase I enrollment

VG Life Sciences said investigators completed enrollment of about 24 patients with refractory or relapsed solid

Read the full 169 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE